Clinical Trial Update: Immediate Versus Deferred Androgen Deprivation Therapy,Goserelin for Recurrent Prostate Cancer After Radical Radiotherapy [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial comparing immediate versus deferred androgen deprivation therapy with goserelin for recurrent prostate cancer after radical radiother…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Zoladex (goserelin)

Snippet

Sponsor: Ontario Clinical Oncology Group (OCOG) | Conditions: Prostate Cancer | Phase 3 | Status: COMPLETED